Delivery Order SPE2DB24D2205-SPE2DB25FEGDS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,809.09 to AmerisourceBergen Drug Corp for 90 capsules of Lyrica 25 mg, a neurological medication commonly used to treat neuropathic pain and fibromyalgia. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of July 22, 2025. The order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $11,106.53 to AmerisourceBergen Drug Corp for 90-count bottles of Lyrica 100 mg capsules. This contract was competitively awarded with no set-aside designation and operates under a firm fixed price structure, with an ultimate completion date of August 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- This federal contract award, valued at $3,231.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lyrica 100 mg capsules, a medication used to treat various conditions including neuropathic pain, fibromyalgia, and seizures. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.57 firm-fixed-price contract is for the delivery of Lyrica 75 mg capsules, a prescription medication for the treatment of neuropathic pain. The contract has a completion date of December 10, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,170.96 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location, leveraging its extensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,550.74 for 90 capsules of Lyrica 100 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGDSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,550.74 to AmerisourceBergen Drug Corp for 90-count bottles of Lyrica 100 mg capsules, a neurological medication commonly used to treat neuropathic pain and fibromyalgia. The contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award was issued under a competitive procurement process and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare systems globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across multiple therapeutic domains, including specialty medications, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/12/25 |